| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |
|
|
|
||||||
|
||||||||
Comparative Study |
Chair and Division of Hematology, University Hospital, Udine, Italy.
BACKGROUND AND OBJECTIVE: Since hepatitis C virus (HCV) infection has been associated with different histotypes of B-cell non-Hodgkin's lymphoma (NHL), with or without concomitant production of cryoglobulins (cryolg), we have investigated the prevalence of the infection among NHL with the aim of defining its relationship with the histotype and with the production of cryolg. METHODS: Four-hundred and seventy unselected, consecutive patients with a diagnosis of B-cell NHL were investigated. Anti-HCV antibodies (Ab) and cryolg were sought in all while HCV RNA and rheumatoid factor were detected on HCV-Ab positive samples. RESULTS: Overall, the prevalence of HCV infection was 8.9% (42/470). It was 95.4% (#21) among the 22 patients with, and 4.6% (#21) among the 448 without production of cryoIg. The most common histotype among the HCV-positive, cryoIg-producing cases, was the immunocytoma (16/21, 76%). Among the HCV-positive, non cryoIg-producing cases, the marginal zone and the follicle center lymphomas were the commonest. INTERPRETATION AND CONCLUSIONS: Close association between HCV infection and cryoIg production, already described in mixed cryoglobulinemia, is confirmed also among B-cell NHL. Nevertheless, 50% of HCV-related lymphomas are non-cryoIg producers. Low-grade lymphomas (in particular the immunocytoma) are the most frequent HCV-related lymphomas. Since new therapeutic strategies might be necessary if the virus is detected, screening for cryoIg and for HCV-Ab among B-cell NHL at diagnosis is mandatory.
This article has been cited by other articles:
|
|
 |
|
  V. De Re, S. De Vita, D. Sansonno, D. Gasparotto, M. P. Simula, F. A. Tucci, A. Marzotto, M. Fabris, A. Gloghini, A. Carbone, et al. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses Rheumatology, June 1, 2006; 45(6): 685 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D Cowgill, C. A Loffredo, S. A.-L. Eissa, N. Mokhtar, M. Abdel-Hamid, A. Fahmy, and G T. Strickland Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt Int. J. Epidemiol., October 1, 2004; 33(5): 1034 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Turner, G. Dusheiko, and A. Jones Hepatitis C and B-cell lymphoma Ann. Onc., September 1, 2003; 14(9): 1341 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Franco, A. M. Florena, and E. Iannitto Splenic marginal zone lymphoma Blood, April 1, 2003; 101(7): 2464 - 2472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Rabkin, B. H. Tess, R. E. Christianson, W. E. Wright, D. J. Waters, H. J. Alter, and B. J. van den Berg Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia Blood, May 13, 2002; 99(11): 4240 - 4242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ramos-Casals, O. Trejo, M. Garcia-Carrasco, R. Cervera, and J. Font Mixed cryoglobulinemia: new concepts Lupus, February 1, 2000; 9(2): 83 - 91. [Abstract] [PDF]
|
|
|
|
 |
|
 D. L. Menkes, D. E. Palmer-Toy, and E T. Hedley-Whyte Case 3-1999- A 41-Year-Old Woman with Muscle Weakness, Painful Paresthesias, and Visual Problems N. Engl. J. Med., January 28, 1999; 340(4): 300 - 307. [Full Text] [PDF]
|
|
|
|
|
|
M. Ivanovski, F. Silvestri, G. Pozzato, S. Anand, C. Mazzaro, O. R. Burrone, and D. G. Efremov Somatic Hypermutation, Clonal Diversity, and Preferential Expression of the VH 51p1/VL kv325 Immunoglobulin Gene Combination in Hepatitis C Virus-Associated Immunocytomas Blood, April 1, 1998; 91(7): 2433 - 2442. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |
